Pravin Dugel - 18 Dec 2022 Form 4 Insider Report for IVERIC bio, Inc.

Role
President
Signature
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Pravin U. Dugel
Issuer symbol
N/A
Transactions as of
18 Dec 2022
Net transactions value
$0
Form type
4
Filing time
20 Dec 2022, 18:00:44 UTC
Previous filing
21 Nov 2022
Next filing
22 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISEE Common Stock Options Exercise $0 +13,750 +11% $0.000000 136,223 18 Dec 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISEE Restricted Stock Units Options Exercise $0 -13,750 -33% $0.000000 27,500 18 Dec 2022 Common Stock 13,750 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units.
F2 On December 18, 2020, the Reporting Person was granted 55,000 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan.